Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to improve muscle strength measurements for ICU patients

NCT ID NCT06296381

Knowledge-focused Sponsor: University of Pernambuco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how to measure muscle strength in healthy individuals and patients in the intensive care unit (ICU). Muscle strength is important for overall health and can predict outcomes in critical illness. Researchers will use handheld devices to measure strength and create reference equations for the Brazilian population, which currently lack standardization. The goal is to make these measurements more reliable for clinical use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide better tools for measuring muscle strength in Brazilian patients, helping doctors assess health and recovery more accurately.
What could go wrong
This is an observational study, not a treatment trial. It may not lead to immediate clinical changes, and the reference equations may need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The population comprised adult and elderly individuals of both sexes able to do volitional tests. For the healthy sample, volunteers without barriers to the assessment of peripheral muscle strength will meet the inclusion criteria while, for the critical patient population, the sample will include individuals hospitalized in the Intensive Care Unit (ICU) who also do not have barriers to the assessment.

Ages

18 to 90 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy individuals of both sexes * Patients and volunteers aged between 18 and 90 years old (youth/adults/elderly). * Patients admitted to the ICU. * No recent muscle injuries of both limbs for a past 6-months. Exclusion Criteria: Patients and volunteers \< 20 years and \> 90 years Healthy individuals * Unable to follow command completely * Severe osteoporosis or neuromuscular disease leading to decreased muscle strength * Presence of opened or infectious wound * Presence of pain in evaluating muscle groups Patients in ICU * Unable to follow command completely * Acute stroke * Hip fracture, unstable cervical spine or pathological fracture * Recent surgery involving the upper airways, chest, abdomen, or limbs * Presence of opened or infectious wound * Presence of pain in evaluating muscle groups

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intensive care unit are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intensive care unit Muscle strength

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Complexo Hospitalar Unimed Recife - CHUR

    RECRUITING

    Recife, Brazil, 50070470, Brazil

  • Federal University of Pernambuco (UFPE)

    RECRUITING

    Recife, Pernambuco, 50740-600, Brazil

  • Hospital Nossa Senhora das Graças

    ACTIVE_NOT_RECRUITING

    Recife, Pernambuco, 51030-020, Brazil

  • Hospital Otávio de Freitas

    RECRUITING

    Recife, Pernambuco, 50920-460, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.